Delivery Order SPE2DB22D2206-SPE2DB26FDR68
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Aprepitant 40 mg capsules in unit dose packages of five, with a ceiling value of $2,107.60 and a firm fixed price structure. This competitively awarded, non-set-aside contract is scheduled for completion by June 12, 2025, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. Aprepitant is a chemotherapy-induced nausea and vomiting (CINV)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (5-count) on July 24, 2025, with a contract ceiling value of $1,698.52 and ultimate completion date of July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was performed at the vendor's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,247.16 to AmerisourceBergen Drug Corp for Aprepitant 125 mg capsule unit dose packages (quantity 6). This non-set-aside, firm fixed price delivery order was awarded on October 20, 2025, with an ultimate completion date of October 21, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $1,459.88 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (quantity 5) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,758.31 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of 5s. The award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under the...
- The Defense Logistics Agency awarded a $12,392.75 delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 125 mg capsules (unit dose, 6 count packaging) with a completion date of July 31, 2025. This non-set-aside, firm fixed price contract was awarded competitively on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,390.80 Firm Fixed Price Delivery Order is for the supply of Aprepitant 80 mg capsules, a medication used to prevent nausea and vomiting associated with chemotherapy. The contract has a period of performance through June 13, 2024 and was awarded on June 12, 2024. The place of performance is Conshohocken, PA. This award is a delivery order under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $2,788.48, is for the supply of APREPITANT 40 MG CAPSULE UD 5S, a type of prescription medication. The contract has a firm fixed price pricing type and a completion date of November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This federal contract award, valued at $4,162.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product, with a performance period extending through April 2025. The contract is a delivery order and is priced on a firm-fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
- The Defense Logistics Agency awarded a $4,792 delivery order to Amerisourcebergen Drug Corporation for 4562020402 Aprepitant 40 mg capsules under a firm fixed price contract. The order is for an unspecified quantity of the drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 1, 2023 to support the Defense Logistics Agency's medical supply needs. No additional details were provided regarding the larger vehicle or any subcontractors involved. The...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDR68Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Aprepitant 40 mg capsules in unit dose packages of 5s, with a ceiling value of $3,674.66 and an ultimate completion date of October 21, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Aprepitant is a chemotherapy-induced nausea and vomiting prevention medication commonly used in military and veteran healthcare settings. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a pharmaceutical prime vendor, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. The company's extensive federal contract portfolio demonstrates its established capability to meet Defense Logistics Agency procurement requirements through competitive bidding, serving critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 10/20/25 |